Figure 1
Ages at diagnosis of polycythemia, pheochromocytoma (PHEO)/paraganglioma (PGL) and somatostatinoma (SOM) for individual patients in chronological order. Ages at latest outpatient visit, gender, mutation status with (‡) and without (†) mosaicism of HIF2A, numbers (multiple = >3), sites (right, left) and recurrence (recur.) of lesions, presence of metastatic disease (MET) and number of surgical interventions (1st – 4th Sx, etc.) and/or radiotherapy (Rx) are indicated.
